共 19 条
- [1] Widdifield J(2015)Trends in excess mortality among patients with rheumatoid arthritis in Ontario, Canada Arthritis Care Res. (Hoboken) 67 1047-1053
- [2] del Rincón ID(2001)High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum. 44 2737-2745
- [3] Williams K(2015)The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis Ann. Rheum. Dis. 74 480-489
- [4] Stern MP(2014)Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment Rheumatology (Oxford) 53 2143-2154
- [5] Freeman GL(2012)Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis Arthritis Rheum. 64 42-52
- [6] Escalante A(2006)Patterns of cardiovascular risk in rheumatoid arthritis Ann. Rheum. Dis. 65 1608-1612
- [7] Roubille C(2011)Number of cardiovascular risk factors may be associated with higher disease activity severity, exploratory analysis of baseline data from the Canadian Methotrexate and Etanercept Outcome Study: a randomized trial of etanercept and methotrexate versus etanercept alone in rheumatoid arthritis Arthritis Rheum. 63 S488-undefined
- [8] Choy E(undefined)undefined undefined undefined undefined-undefined
- [9] Ganeshalingam K(undefined)undefined undefined undefined undefined-undefined
- [10] Semb AG(undefined)undefined undefined undefined undefined-undefined